Welcome to this bonus episode of Our MBC Life. Our team is currently working on season 2 and we are excited. The premiere episode will drop on March 1.  While we do that, we hope you catch up on any episodes you missed from Season 1.  We will have 3 more bonus pods for you in January and February. 

Our MBC Life is a part of the metastatic breast cancer program at SHARE Cancer Support. SHARE has many programs to support women living with MBC including the Talk METS Helpline, several virtual support groups, and educational and wellness programs. We are thrilled to highlight some of those programs in January.   It feels like a lifetime ago, but just a few weeks ago the world's largest breast cancer conference, the San Antonio Breast Cancer Symposium, was held.  Just after the symposium SHARE welcomed Dr. Neil Iyengar from Memorial Sloan Kettering to a webinar where he shared information from SABCS highlighting both early-stage and metastatic research. We are pleased to have that conversation to start the year and catch you up on the latest in MBC research.  

Christine Benjamin,  the senior director of patience services and education from SHARE Cancer Support and the new Chair of the Metastatic Breast Cancer Alliance, speaks with Dr. Iyengar.  

LINKS AND RESOURCES MENTIONED IN THE EPISODE:

FDA Approves Margetuximab-cmkb Plus Chemo in Pretreated Metastatic HER2+ Breast Cancer

Phase 2a Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer

Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus germline BRCA mutations.

What is MBC Connect?

Four FDA Approvals for HER2+ Breast Cancer in the Past 2 Years Have Led to Transformative Treatment Outcomes

AKT Inhibitor Disappoints in Tough-to-Treat Breast Cancer

SABCS 2020: Novel Oral Taxane Demonstrates Efficacy in CONTESSA Trial

Diabetes Prevention Diet

Clinical Trials

TROPICS-02

IPATunity130

CONTESSA

RxPONDER

DEDiCa

IMpassion031

KEYNOTE-355

EMERALD

PALOMA-3

MONALEESA-7

NATALEE

OVERVIEW
00:01:40 - Introductions. (Jump to section)

00:06:04 - Early Stage Breast Cancer (BC). (Jump to section)

00:23:41- General Remarks about MBC. (Jump to section)

00:25:41 - Hormone Positive (ER+/PR+) MBC. (Jump to section)

00:31:40 - Triple Negative (TNBC) MBC. (Jump to section)

00:36:02 - HER2 Positive (HER2+) MBC. (Jump to section)

00:45:00 - Lifestyle Research (Jump to section)

00:47:28 - Question #1 about leptomeningeal disease. (Jump to section)

00:49:24 - Question #2 about oral SERDs. (Jump to section)

00:50:23 - Question #3 - should all MBC patients get genetic testing? (Jump to section)

00:52:21 - Question #4 about Lobular MBC.  (Jump to section)

I hope you found this helpful. And let's go ahead and open it up to questions. Thank you.